Related Experiment Video
Updated: May 20, 2026

A Mouse Abdominal Aortic Aneurysm Model by Periadventitial Calcium Chloride and Elastase Infiltration
Published on: August 2, 2024
Effects of statin therapy on abdominal aortic aneurysm growth: a meta-analysis and meta-regression of observational
H Takagi1, H Yamamoto, K Iwata
1Department of Cardiovascular Surgery, Shizuoka Medical Center, 762-1 Nagasawa, Shimizu-cho, Shizuoka 411-8611, Japan. kfgth973@ybb.ne.jp
Objective:
To determine whether statin therapy reduces the growth rate of small abdominal aortic aneurysms (AAAs).
Design:
A meta-analysis and a meta-regression of comparative studies.
Materials:
Eligible studies were randomized controlled trials or observational comparative studies of statin therapy versus placebo or no statin, enrolling individuals with small (<55 mm in diameter) AAAs and reporting AAA growth rate as an outcome.
Methods:
Study-specific estimates (standardized mean differences [SMDs]) were combined in the fixed- and random-effects model.
Results:
Seven adjusted and 4 unadjusted observational comparative studies enrolling 4647 patients with a small AAA were identified. Pooled analysis of all 11 studies suggested a significant reduction in AAA growth rate among patients assigned to statin therapy versus no statin (SMD, -0.420; 95% confidence interval [CI], -0.651 to -0.189). Combining the 7 high-quality studies providing adjusted data for growth rates generated an attenuated but still statistically significant result favoring statin therapy (SMD, -0.367; 95% CI, -0.566 to -0.168). The meta-regression coefficient for the baseline diameter was statistically significant (-0.096; 95% CI, -0.132 to -0.061).
Conclusion:
Statin therapy is likely effective in prevention of the growth of small AAAs, and may be more beneficial as the baseline diameter increases.
Related Concept Videos
Atherosclerosis III: Management
Aneurysm III: Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation III: Medical Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
